Processing to inactivate pathogens |
-
•
Lack of research into novel non-thermal technologies (e.g., high-pressure processing, ultraviolet C-irradiation, ultrasonication).
-
•
No literature on implementing hurdle technology in milk processing (e.g., applying >1 method to achieve improved pathogen inactivation).
|
-
•
Protein digestion, release of peptide and bioactivity of peptides.
-
•
Impact on fat lipolysis and fat absorption.
|
-
•
New non-thermal methods may result in improved patterns of peptide generation and release that could have implications relating to host defense and overall health.
-
•
Preservation of lipase activity via the application of non-thermal methods has the potential to improve fat digestion among preterm infants receiving donor milk.
-
•
Hurdle technology may strike the appropriate balance between preservation of milk function/ digestibility and inactivating pathogens.
|
Processing to ensure homogenous donor milk fat composition |
|
-
•
Impact on milk fat globule, fat lipolysis and absorption.
-
•
Consistency in donor milk product/ability to tightly regulate composition.
-
•
Adherence to tubing required for feeding preterm infants.
|
-
•
Homogenization has the potential to improve the distribution of fat during donor milk processing and may improve digestion and absorption.
-
•
During feeding, homogenized milk may adhere less to tubing, increasing the overall delivery of fat to the infant.
|
Freeze-thawing and duration of freezing |
-
•
Extremely limited research (only 1 in vitro study) into the impact of freeze-thawing, as well as the conditions during freezing (e.g., temperature, time duration etc.) on outcomes relating to digestion and absorption.
-
•
No in vivo studies found.
|
-
•
Protein digestion/hydrolysis, peptide release and bioactivity of peptides.
-
•
Lipolysis and fat absorption.
|
|